PTCs also revealed an increased sensitivity to ferroptosis, suggesting a protective role of HO-1 in 61 ferroptosis. In line with these data, it was previously demonstrated that genetic absence of HO-1 62 sensitizes mice to cisplatin-induced AKI, and that the induction of HO-1 expression by addition of the 63 molecule hemin to human renal tubules reduced necrotic damage(13). Also in hepatocellular 64 carcinoma cells, a protective role for the NRF2-HO-1-pathway was observed in response to erastin-65 and sorafenib-induced ferroptosis (14) . 66
The extraordinary role of ferroptosis in renal tubules is highlighted by three hallmark observations. 67
Firstly, inducible deletion of GPX4 in renal tubules results in massive tubular necrosis that is 68 prevented by the ferroptosis inhibitor liproxstatin-1(3). Secondly, all renal clear cell carcinoma cell 69 lines in the NCI tumor panel were sensitive to RSL3-mediated ferroptosis (16) . Lastly, prevention of 70 ferroptosis in murine models of acute kidney injury resulted in remarkable preservation of renal 71 function, even upon otherwise lethal ischemic damage(9). In contrast to other clinically relevant forms 72 of regulated necrosis, such as necroptosis or pyroptosis, ferroptosis exhibits the only known cell death 73 pathway that is capable of inducing synchronized regulated necrosis (SRN) in functional units ofinterconnected cells in a non-cell autonomous manner(8). Importantly, this effect does not appear to be 75 limited to renal tubules. Recently, cell culture models have been employed to detect similar effects that 76 are mediated by ferroptosis(6). With this growing mechanistic understanding of ferroptosis and its 77 regulation, novel methodological approaches may allow more detailed research. In this sense, ACSL4 78 was recently demonstrated to mediate ferroptotic cell death(2, 5), providing the opportunity to 79 generate tubular cell specific knockout of ACSL4. 80
Several obstacles remain related to the mechanisms of ferroptosis during acute kidney injury. One 81 major question to address is the measurement of free or labile iron inside the cellular cytoplasm. This 82 is of particular importance because the reaction that is catalysed by HO-1 releases free iron (Fe 2+ ) from 83 heme and should increase the labile iron pool (LIP), which was postulated to contribute to the 84 cytotoxicity already in 1999(15) More recently, this idea was further supported by the finding that 85 HO-1 is accelerating erastin-induced ferroptosis in fibroblasts(7). This cytotoxic versus cytoprotective 86 action of HO-1 might be related to the iron buffering capacity of the cells (such as ferritin) or the 87 expression levels of the iron export protein ferroportin. Should this capacity be interfered with, e.g. by 88
genetic targeting, tubular cells could no longer keep control about their free iron content, which may 89 result in detrimental necrosis and systemic inflammation. Therefore, the results presented in the 90 current work, together with previously published knowledge about HO-1 biology(11), suggest a faint 91 and tightly regulated balance between ferritin, free iron and HO-1 activity. It will be important to 92 investigate these balances in more detail to understand ferroptotic tubular necrosis and its inevitably 93 associated inflammatory response -not only for AKI, but also for kidney transplantation and possibly 94 ischemic injury in many other organ systems. In addition, the work by Adedoyin et al. provides an 95 important in vitro link between HO-1 and ferroptosis. In vivo, HO-1 therefore should control local 96 necroinflammation(10) and indirectly regulate systemic inflammation and distant organ effects in 97 AKI(4). 98 99 "We didn´t start the fire". 100 101
